Eli Lilly (NYSE:LLY) shares snapped six straight sessions of losses on Thursday, as the stock closed 2.7% higher at $797.45.
Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...
Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...
Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...
Ricks is being recognized for his contributions to Indiana’s life sciences sector and his global impact on health care ...
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...
Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased a 323,930-square-foot industrial building in the ...
INDIANAPOLIS -- Eli Lilly dialed back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales ...
Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations INDIANAPOLIS -- Eli Lilly is dialing ...